ESC Premium Access

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Congress Session

About the speaker

Doctor Miho Sugitani

Nishinomiya (Japan)
0 follower

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Hyogo, JP)

Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)

Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Thumbnail

Outcomes and resource utilization of atrial fibrillation hospitalizations with type 2 myocardial infarction

Speaker: Mr R. Ariss (Toledo, US)

Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Doctor M. Sugitani, Associate Professor T. Mine, Mr T. Klamer, Doctor M. Mansour, Doctor C. Boerschel...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

The role of modifiable risk factors for the maintenance of sinus rhythm in the atrial fibrillation patient.

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

The ECG and beyond: artificial intelligence will penetrate cardiology practice.

27 August 2021

This platform is supported by

logo Novo Nordisk